Correlation of [18F]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 10, 2008, Pages 1803-1811

  Troost, Esther G C ^a   Laverman, Peter ^a   Philippens, Mariëlle E P ^a   Lok, Jasper ^a   Van Der Kogel, Albert J ^a   Oyen, Wim J G ^a   Boerman, Otto C ^a   Kaanders, Johannes H A M ^a   Bussink, Johan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F Fluoromisonidazole; Digital autoradiography; Hypoxia; Immunohistochemistry; Pimonidazole

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; PIMONIDAZOLE; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MISONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER SCINTISCANNING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACCUMULATION; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOISOTOPE DISTRIBUTION; TUMOR XENOGRAFT; ANIMAL; COMPARATIVE STUDY; EVALUATION; HEAD AND NECK TUMOR; METABOLISM; METHODOLOGY; NUDE MOUSE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; AUTORADIOGRAPHY; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; MISONIDAZOLE; NITROIMIDAZOLES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 52449099235     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0772-7     Document Type: Article

References (34)

1. J Bussink JH Kaanders AJ van der Kogel 2003 Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers Radiother Oncol. 67 3 15
2. D Hedley M Pintilie J Woo A Morrison D Birle A Fyles 2003 Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas Clin Cancer Res. 9 5666 5674
3. M Nordsmark SM Bentzen V Rudat D Brizel E Lartigau P Stadler 2005 Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol. 77 18 24
4. M Nordsmark M Hoyer J Keller OS Nielsen OM Jensen J Overgaard 1996 The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas Int J Radiat Oncol Biol Phys. 35 701 708
5. M Nordsmark J Overgaard 2000 A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy Radiother Oncol. 57 39 43
6. JH Kaanders LA Pop HA Marres I Bruaset FJ van den Hoogen MA Merkx 2002 ARCON: experience in 215 patients with advanced head-and-neck cancer Int J Radiat Oncol Biol Phys. 52 769 778
7. J Overgaard HS Hansen M Overgaard L Bastholt A Berthelsen L Specht 1998 A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85 Radiother Oncol. 46 135 146
8. L Bentzen S Keiding M Nordsmark L Falborg SB Hansen J Keller 2003 Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours Radiother Oncol. 67 339 344
9. E Lartigau L Vitu C Haie-Meder MF Cosset M Delapierre A Gerbaulet 1992 Feasibility of measuring oxygen tension in uterine cervix carcinoma Eur J Cancer. 28 1354 1357
10. M Nordsmark J Loncaster C Aquino-Parsons SC Chou M Ladekarl H Havsteen 2003 Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas Radiother Oncol. 67 35 44
11. CJ Koch SM Evans EM Lord 1995 Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity Br J Cancer. 72 869 874
12. JA Raleigh DP Calkins-Adams LH Rinker CA Ballenger MC Weissler WC Fowler Jr. 1998 Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker Cancer Res. 58 3765 3768
13. SM Evans S Hahn DR Pook WT Jenkins AA Chalian P Zhang 2000 Detection of hypoxia in human squamous cell carcinoma by EF5 binding Cancer Res. 60 2018 2024
14. Yaromina, et al. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother Oncol. 2006;81(2):122-9.
15. JH Kaanders KI Wijffels HA Marres AS Ljungkvist LA Pop FJ van den Hoogen 2002 Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Res. 62 7066 7074
16. L Bentzen S Keiding MR Horsman T Gronroos SB Hansen J Overgaard 2002 Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing Acta Oncol. 41 304 312
17. SM Eschmann F Paulsen M Reimold H Dittmann S Welz G Reischl 2005 Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy J Nucl Med. 46 253 260
18. WJ Koh JS Rasey ML Evans JR Grierson TK Lewellen MM Graham 1992 Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole Int J Radiat Oncol Biol Phys. 22 199 212
19. JS Rasey WJ Koh ML Evans LM Peterson TK Lewellen MM Graham 1996 Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients Int J Radiat Oncol Biol Phys. 36 417 428
20. D Sorger M Patt P Kumar LI Wiebe H Barthel A Seese 2003 [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors Nucl Med Biol. 30 317 326
21. EG Troost P Laverman JHAM Kaanders M Philippens J Lok WJG Oyen AJ van der Kogel OC Boerman J Bussink 2006 Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors Radiother Oncol 80 157 164
22. MT Wyss M Honer PA Schubiger SM Ametamey 2005 NanoPET imaging of [(18)F]fluoromisonidazole uptake in experimental mouse tumours Eur J Nucl Med Mol Imaging 33 311 318
23. RJ Hicks D Rischin R Fisher D Binns AM Scott LJ Peters 2005 Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent Eur J Nucl Med Mol Imaging. 32 1384 1391
24. D Rischin RJ Hicks R Fisher D Binns J Corry S Porceddu 2006 Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02 J Clin Oncol. 24 2098 2104
25. D Thorwarth SM Eschmann F Holzner F Paulsen M Alber 2006 Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients Radiother Oncol. 80 151 156
26. KWM Allemann M Wergin S Ohlerth C Rohrer-Bley SM Evans AP Schubiger SM Ametamey B Kaser-Hotz 2005 Measurements of hypoxia ([18F]-FMISO, [18F]-EF5) with positron emission tomography (PET) and perfusion using PET ([15O]-H2O) and power Doppler ultrasonography in feline fibrosarcomas Vet Comp Oncol. 3 211 221
27. A Pugachev F Claus X Sun S Cai J Koziorowsky R Finn 2005 Validation of PET hypoxia tracers by autoradiography and fluorescent microscopy Med Phys. 32 2055
28. T Tanaka T Furukawa S Fujieda S Kasamatsu Y Yonekura Y Fujibayashi 2006 Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models Nucl Med Biol. 33 743 750
29. H Yuan T Schroeder JE Bowsher LW Hedlund T Wong MW Dewhirst 2006 Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) J Nucl Med. 47 989 998
30. AS Ljungkvist J Bussink PF Rijken JH Kaanders AJ van der Kogel J Denekamp 2002 Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas Int J Radiat Oncol Biol Phys. 54 215 228
31. JL Lim MS Berridge 1993 An efficient radiosynthesis of [18F]fluoromisonidazole Appl Radiat Isotopes 44 1085 1091
32. PF Rijken HJ Bernsen JP Peters RJ Hodgkiss JA Raleigh AJ van der Kogel 2000 Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis Int J Radiat Oncol Biol Phys. 48 571 582
33. FJ Hoebers HL Janssen AV Olmos D Sprong AD Nunn AJ Balm 2002 Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21 Eur J Nucl Med Mol Imaging. 29 1206 1211
34. EG Troost J Bussink JH Kaanders J van Eerd JP Peters PF Rijken 2005 Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines Radiother Oncol. 76 194 199